OPINION: Who is next in cannibalistics capitalism?
Aspen Pharmacare fell by nearly 29percent on Friday, wiping R20billion off its market value at the close, while Tongaat-Hulett saw its share price perish by more than 43percent since last Thursday, wiping off nearly R2bn of its market value.
It sure does smack of capitalism that has been cannibalised.
Business Insider in 2015 quoted a correspondent's post on the subject: “The modern banking system of the last few centuries has been based on lending to borrowers who do something productive with the capital - open a mine, start a factory, start a ranch, drill an oil well. But this whole equation becomes unstuck when - because of a finite resource-constrained planet - there's nowhere productive to invest it anymore. That’s when finance capital becomes cannibalistic, as it has over the last few decades. That’s why the Greeks, for example, cannot grow themselves out of the debt pit - there’s no growth to be had.”
To me capitalism becomes cannibalistic when the practices and processes followed by greedy corporates and their executives, not only for the sake of growth at all cost, but also for their own pockets as their total remuneration packages are normally linked to the company's financial performance and even more so, the performance of the company's share price. Your savings or investment could be used by the companies to buy overinflated assets, even sometimes from some of their own executives, or put your savings at risk by overleveraging companies through excessive borrowings.
Profits can be overstated and/or all sorts of funnies done to make the financials look better. Yes, your savings are used by your fund manager, retirement fund or yourself to invest in a company where all of you are unaware of any malfeasance by the company's executives and the company's external auditors.
Tongaat fell after the company advised shareholders that a comprehensive review of practices might impact on previously reported financial information - that was on top of a very disappointing trading update and trading statement of the company released in late February. (Tongaat’s share price is now down by more than 65 percent, amounting to R4.1bn being wiped prior to the release of the trading update.)
How can a highly qualified analyst or fund manager with similar qualifications as the external auditors of the company question the audit of a reputable audit firm and accounting practices?
The extreme form of cannibalistic capitalism to me involves short-selling where a short seller makes money when share prices fall.
Short-selling effectively means the selling of equities which you do not own with the objective and hope that the price of the asset declines to a level where you can buy it back and make a profit.
The practices and processes involve securities lending whereby the owner of shares transfers the equities temporarily to the short-seller. In return, the borrower transfers other shares, bonds or cash to the lender as collateral and pays a borrowing fee to the lender. The borrower agrees to return the identical shares or bonds to the lender at some stage in the future when the collateral assets are returned to the borrower.
It is virtually impossible for the ordinary investor or fund manager to observe the share lending activities, though. Ordinary investors and even fund managers can be caught totally unawares if a share price suddenly starts to fall on increased volumes as a result of some of the borrowed stock entering the market.
Short-selling and the lending of securities in normal circumstances are quite healthy for the financial markets. Those analysts who detect that something is wrong with a company should be rewarded as short positions can be built long before a major negative announcement about a company is made.
With hindsight it seems that the market was oblivious to the bad results Aspen telegraphed in its pre-close statement in mid-December last year and that could be conducive to an environment where short-sellers roam.
Aspen fell hard with the announcement of the disappointing interim results last week while the drug maker’s balance sheet deteriorated due to increased net borrowings, casting doubt on the company's future prospects.
Some analysts who “live” close to Tongaat had their reservations about the company's direction. For others, the sell-off in February provided an opportunity as the share traded at a significant discount to the stated net asset value of the share.
According to Morningstar, the current Price/book value ratio of Tongaat is 0.20 but no one knows whether the book value will be adjusted downwards. What happened is history.
Short-selling unfortunately opens the way for abuse as well. It is especially relevant in regard to insider trading and market manipulation. Worst of it all, well-managed but relatively highly geared companies - those with high debt - may suddenly discover that their credit lines and customer base dry up resulting in an implosion of the company and its share price.
Very large retirement funds may lend out stock at their peril or use stock as collateral - you simply do not know what the counter party may do as they can actually use it to take positions against you.
It has happened with well-known names. The jury is out on who is next. Unfortunately we as savers end up being the victims of cannibalised capitalism.
Ryk de Klerk is an independent analyst. Contact [email protected] His views expressed above are his own. You should consult your broker and/or investment adviser for advice.